TRB Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026TRB Wealth Management, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $18.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$18.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,405 | $4.1M |
| JNJJOHNSON & JOHNSON | 14,241 | $3.5M |
| ABBVAbbVie Inc. | 12,846 | $2.8M |
| PMPhilip Morris International Inc | 10,933 | $1.8M |
| MRKMerck & Co., Inc. | 8,933 | $1.1M |
| PFEPFIZER INC | 27,310 | $767K |
| ABTABBOTT LABORATORIES | 7,152 | $734K |
| GILDGILEAD SCIENCES, INC. | 4,465 | $622K |
| AMGNAMGEN INC | 1,725 | $607K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,948 | $527K |
| MCKMcKesson Corporation | 372 | $322K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 711 | $317K |
| GMOptec International, Inc. | 3,754 | $280K |
| BMYBRISTOL MYERS SQUIBB CO | 4,453 | $270K |
| NVONovo Nordisk A/S | 6,798 | $256K |
| REGNREGENERON PHARMACEUTICALS, INC. | 330 | $255K |
| IQVIQVIA Holdings Inc. | 1,241 | $212K |
| BIIBBIOGEN INC. | 1,097 | $201K |
| CTMXCytomX Therapeutics, Inc. | 13,435 | $63K |
| CLOVClover Health Investments Corp. | 13,765 | $24K |
| CHRSCoherus Oncology, Inc. | 11,326 | $19K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.